First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients
Crossref DOI link: https://doi.org/10.1007/s40272-016-0194-0
Published Online: 2016-09-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yüksel, Selçuk
Evrengül, Havva
Özçakar, Z. Birsin
Becerir, Tülay
Yalçın, Nagihan
Korkmaz, Emine
Ozaltin, Fatih
License valid from 2016-09-19